Key facts
- Cryogenx’s last known valuation is $7.9M (Jul 2025).
- It has raised $2.8M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Innovate UK, Future Planet Capital, UK Innovation & Science Seed Fund, Connected Places Catapult, Undaunted — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Cryogenx
- ·The full record, as it builds
Funding rounds
No funding rounds for Cryogenx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cryogenx
Manufacturer of a portable medical cooling device intended to treat heat-related illness and protect people from extreme heat exposure. The company offers a deployable core body cooling device that overcomes logistical and performance limitations of existing treatment methods, enabling healthcare providers, emergency responders, and heat-exposed workers to deliver timely heatstroke care and reduce the risk of death and injury.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 7
- Website
- cryogenx.com/
- Ownership
- Privately Held (backing)
Cryogenx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cryogenx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cryogenx in its N-PORT filings yet. We sweep new filings monthly.